Sandeep Agarwal

Novyra Pharmachem Limited proposes a capital reduction scheme to cancel 85.71% of its equity share capital (54.25 lakh shares) to write off accumulated losses of ₹5.42 crore. The company reported a ne

Novyra Pharmachem Ltd convenes its 39th AGM on June 25, 2026, to seek shareholder approval for key resolutions including financial statement adoption. Proposes special resolution to reduce paid-up cap